Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_assertion type Assertion NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_head.
- NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_assertion wasGeneratedBy ECO_0000203 NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_provenance.
- NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_assertion wasDerivedFrom befree-2016 NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_provenance.
- NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_assertion SIO_000772 22447153 NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_provenance.
- NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_assertion evidence source_evidence_literature NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_provenance.
- NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_assertion description "[In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X-ALD fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP970252.RA8rdMXxRJuJU1JGnYEf3iKDc5yS6iTJw1SlawcdEwbZs130_provenance.